Tender to supply ARVs awarded to companies
The national Department of Health has announced the names of various pharmaceutical companies that have won the three year tender to supply antiretroviral (ARVs) to millions of patients on treatment in South Africa.
© Monika Wisniewska - Fotolia.com
The tender for the 2015 - 2017, worth over R10 billion was awarded to Sonke Pharmaceuticals R3 billion, Mylan Pharmaceuticals R2.8 billion, Aspen Pharmacare R2.5 billion and Cipla Medpro R2 billion.
There are over 2.7 million people on ARV treatment in South Africa with about 1.5 million receiving the Fixed Dose Combination.
The Fixed Dose Combination was announced by Health Minister Dr Aaron Motsoaledi in April 2013 at Phedisong Clinic, Ga-Rankuwa north of Pretoria.
The department aims to have about 4.6 million people on treatment by the end of 2016.
Source: SAnews.gov.za
SAnews.gov.za is a South African government news service, published by the Government Communication and Information System (GCIS). SAnews.gov.za (formerly BuaNews) was established to provide quick and easy access to articles and feature stories aimed at keeping the public informed about the implementation of government mandates.
Go to: http://www.sanews.gov.zaRelated
Kenya HIV patients live in fear as US aid freeze strands drugs in warehouse 13 Mar 2025 How Afrocentric's Aid for Aids programme is transforming HIV care in South Africa 13 Dec 2024 ARV supply set to triple: South Africa's new plan to tackle HIV 2 Dec 2024 Novo Nordisk contracts Aspen to produce insulin for Africa 20 Sep 2023
